Clinical Trial: Atrial Shunt for the Treatment of Heart Failure With Reduced Ejection Fraction

U.S., Sept. 16 -- ClinicalTrials.gov registry received information related to the study (NCT07820410) titled 'Atrial Shunt for the Treatment of Heart Failure With Reduced Ejection Fraction' on July 16.

Brief Summary: To evaluate the safety and effectiveness of the Atrial Shunt for the treatment of heart failure with reduced ejection fraction (HFrEF)

Study Start Date: Nov. 25, 2024

Study Type: INTERVENTIONAL

Condition: Heart Failure With Reduced Ejection Fraction (HFrEF)

Intervention: DEVICE: D-shant Atrial Shunt

The D-Shant atrial shunt device is a novel device therapy for heart failure, classified as a non-active implantable cardiovascular device. It is manufactured using a braided Nitinol technique, thermally set via assembly mold...